Ziprasidone QT

Ziprasidone QT 구조식 이미지
카스 번호:
884305-07-1
상품명:
Ziprasidone QT
동의어(영문):
Ziprasidone QT;Ziprasidone Impurity 24;Ziprasidone Impurity 23;5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)acetyl)-6-chloroindolin-2-one;2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]acetyl]-6-chloro-1,3-dihydro-;5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-1-oxoethyl)-6-chloro-1,3-dihydro-2H-indole-2-one
CBNumber:
CB03059715
분자식:
C21H19ClN4O2S
포뮬러 무게:
426.92
MOL 파일:
884305-07-1.mol

Ziprasidone QT 속성

끓는 점
601.8±55.0 °C(Predicted)
밀도
1.422±0.06 g/cm3(Predicted)
저장 조건
Store at -20°C
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열)
산도 계수 (pKa)
12?+-.0.20(Predicted)
물리적 상태
고체
물리적 상태
단단한 모양
색상
연한 주황색에서 갈색까지

안전

Ziprasidone QT C화학적 특성, 용도, 생산

용도

Keto Ziprasidone is an intermediate in the synthesis of Hydroxy Ziprasidone which is an impurity of Ziprasidone (Z485000); a combined serotonin (5HT2) and dopamine (D2) receptor antagonist. Used as an antipsychotic.

Ziprasidone QT 준비 용품 및 원자재

원자재

준비 용품


Ziprasidone QT 공급 업체

글로벌( 21)공급 업체
공급자 전화 이메일 국가 제품 수 이점
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131981 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17982 56
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Artis Biotech Co. Ltd. 19138486554 18582380095
sales@artisbio.com China 3066 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7851 55
Chengdu Novel Biomedical Co., Ltd. 028-85255396 18302801538
cdnovell@163.com China 2238 58
Shanghai Han-Xiang Chemical Co., Ltd. 15971444841
amber@biochempartner.com China 3063 58

Copyright 2019 © ChemicalBook. All rights reserved